Both the SPDR S&P Biotech ETF (XBI) and the iShares NASDAQ Biotechnology Index ETF (IBB) extended gains on Thursday afternoon. Both funds have been in an uptrend for the better part of the last 3 days to begin the month of August.

For a number of companies, earnings have taken center stage in recent weeks and for the most part, companies are outperforming previous earnings reports. Heading into the month of August, biotech stocks and healthcare stocks are in focus.
Despite recent market volatility, there are a number of small cap biotech stocks that investors may be watching at the end of July to see what may be on the horizon for the new month ahead.